Abstract
BackgroundNitric oxide (NO) is central in the process of vasodilatation (1). Limited bioavailability of NO often associates with endothelial dysfunction, a precursor to atherogenesis (1). Such dysfunction is often observed...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have